Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for acute mania
NCT01541605Phase 3Completed
- Start
- Mar 2012
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of methylphenidate hydrochloride extended-release chewable tablet in mania. Primary endpoint: Young Mania Rating Scale at 2.5 days. Started Mar 2012; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
mania
Beyond the preview
Go deeper on NCT01541605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541605.